Article Details

RespireRx Pharmaceuticals Inc. Announces Entry into Letter

Retrieved on: 2022-11-17 13:57:39

Tags for this article:

Click the tags to see associated articles and topics

RespireRx Pharmaceuticals Inc. Announces Entry into Letter. View article details on HISWAI: https://www.globenewswire.com/news-release/2022/11/17/2558239/0/en/RespireRx-Pharmaceuticals-Inc-Announces-Entry-into-Letter-of-Intent-with-Australian-Headquartered-CRO-for-Dronabinol-Development-for-Obstructive-Sleep-Apnea.html

Excerpt

Announces Entry into Letter of Intent with Australian Headquartered CRO for Dronabinol Development for Obstructive Sleep Apnea. November 17, 2022 08: ...

Article found on: www.globenewswire.com

View Original Article

This article is found inside other Hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up